News Medical on MSN10d
GLP-1RA initiation linked to new thyroid cancer diagnoses
Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor ...
Nature15d
Resistance to thyroid hormone: one of several defects causing reduced sensitivity to thyroid hormone
TH receptors are nuclear transcription factors ... by investigators at the 8 th International Workshop on Resistance to Thyroid Hormone... Recent discoveries of genetic defects that reduce the ...
Fab World Today on MSN6mon
The Pompa Program and Understanding the Impact on Thyroid Function
The program emphasizes a deep assessment of cellular health and the removal of toxins to restore proper thyroid function and ...
The Lancet14d
The role of the hypothalamic–pituitary–thyroid axis in thyroid cancer
The hypothalamic–pituitary–thyroid axis plays a crucial role in the pathogenesis, diagnosis, risk stratification, effectiveness of radioiodine therapy, and treatment response evaluation in epithelial ...
Glucagon-like peptide-1 receptor agonists tied to higher thyroid cancer risk in first year of treatment
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...
Healio25d
GLP-1 receptor agonists tied to similar thyroid cancer risk as DPP-IV inhibitors
No difference in thyroid cancer risk was found for adults with type 2 diabetes using a GLP-1 receptor agonist vs. those using a DPP-IV inhibitor. Women may have a lower risk for thyroid cancer ...
Nature4y
G-Protein-Coupled Receptors, Pancreatic Islets, and Diabetes
G-protein coupled receptors regulate hormone secretions in the pancreas. Learn how the complex signaling features of these receptors are illuminating diabetes research. Diabetes results from ...